These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7468274

  • 1. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
    Graczyk J, Pakulska W, Groszkowski S, Najman L.
    Acta Pol Pharm; 1980; 37(2):249-54. PubMed ID: 7468274
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of selected piperazine derivatives on the metabolic clearance rate of idoxuridine-I-125 in mice with transplanted leukemia L1210].
    Graczyk J, Kowalczyk K, Pakulska W, Szadowska A.
    Acta Pol Pharm; 1981; 38(6):717-21. PubMed ID: 7348532
    [No Abstract] [Full Text] [Related]

  • 3. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E.
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract] [Full Text] [Related]

  • 4. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC, Booth BA.
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract] [Full Text] [Related]

  • 5. [Antineoplastic activity of complex compounds of platinum(IV)].
    Presnov MA, Zheligovskaia NN, Babkov AV, Konovalova AL, Budanova NS.
    Dokl Akad Nauk SSSR; 1965 Oct; 229(1):226-9. PubMed ID: 954573
    [No Abstract] [Full Text] [Related]

  • 6. Antitumour activity in a series of bisdiketopiperazines.
    Creighton AM, Hellmann K, Whitecross S.
    Nature; 1969 Apr 26; 222(5191):384-5. PubMed ID: 5782118
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and antileukemic properties of 2-methyl and 2,5-dimethylpiperazides.
    Groszkowski S, Najman L.
    Pol J Pharmacol Pharm; 1983 Apr 26; 35(6):517-21. PubMed ID: 6677897
    [Abstract] [Full Text] [Related]

  • 8. [Aromatic N-mustard compounds. 1. Derivatives of 3-N, N-bis-(2-chlorethyl)amino-4-methylbenzoid acid].
    Cambanis A, Gericke D.
    Arzneimittelforschung; 1975 Jan 26; 25(1):1-9. PubMed ID: 1173761
    [Abstract] [Full Text] [Related]

  • 9. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
    He H, Wang MY, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1988 Jul 26; 9(4):369-73. PubMed ID: 3195349
    [No Abstract] [Full Text] [Related]

  • 10. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS, Wood HB, Engle RR, Venditti JM, Goldin A.
    Cancer Chemother Rep 2; 1972 Nov 26; 3(1):137-229. PubMed ID: 4350012
    [No Abstract] [Full Text] [Related]

  • 11. An approach to tumour biology in the light of prevention, cure and etiology.
    Bose S, Chowdhury JR.
    Indian J Cancer; 1972 Jun 26; 9(2):138-41. PubMed ID: 4635904
    [No Abstract] [Full Text] [Related]

  • 12. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E, Nichol CA.
    Cancer Res; 1965 Oct 26; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract] [Full Text] [Related]

  • 13. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ, Burrage K, Hellmann K.
    Cancer Res; 1974 Apr 26; 34(4):843-9. PubMed ID: 4814997
    [No Abstract] [Full Text] [Related]

  • 14. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
    Leiter J, Abbott BJ, Schepartz SA.
    Cancer Res; 1965 Dec 26; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
    [No Abstract] [Full Text] [Related]

  • 15. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.
    Leiter J, Abbott BJ, Schepartz SA.
    Can Res Suppl; 1964 Dec 26; ():1093-353. PubMed ID: 5878218
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.